Federal Contractor Profile
Novartis Pharmaceuticals Corporation
$66M obligated·89 awards·4 agencies·2 NAICS
Federal Contracts
Showing award actions 101–115 of 115 funded award actions, most recent first.
- Contracts with positive obligations
- 89
- Funded award actions shown
- 115
- Obligations shown
- $66M
- Awarding agencies
- 4
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of November 3, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Apr 28, 2020 | Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249) | 36C24920N0454 | 325412 | EMERGENCY TISAGENLECLEUCEL | $284K |
| Apr 6, 2020 | Department of Veterans Affairs257-NETWORK CONTRACT OFFICE 17 (36C257) | 36C25720F0196 | 325412 | KYMRIAH (TISAGEN LECLEUCEL) CANCER MEDICATION | $284K |
| Mar 4, 2020 | Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245) | 36C24520F0380 | 325412 | SIGNIFOR LAR | $37K |
| Feb 26, 2020 | Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249) | 36C24920N0346 | 325412 | EMERGENCY TISAGENLECLEUCEL | $284K |
| Dec 30, 2019 | Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245) | 36C24520F0252 | 325412 | SIGNIFOR 0.6MG | $14K |
| Dec 19, 2019 | Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249) | 36C24920N0244 | 325412 | DRUG TISAGENLECLEUCEL TRADE NAME KYMRIAH FOR CAR-T CELL THEARPY | $285K |
| Oct 18, 2019 | Department of Veterans Affairs249-NETWORK CONTRACT OFFICE 9 (36C249) | 36C24920N0173 | 325412 | DRUG TISAGENLECLEUCEL TRADE NAME: KYMRIAH | $285K |
| Sep 6, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700026C | 541711 | ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF | $636K |
| Jul 31, 2019 | Department of Veterans Affairs242-NETWORK CONTRACT OFFICE 02 (36C242) | 36C24219F0479 | 325412 | KYMRIAH | $284K |
| Apr 10, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700026C | 541711 | ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF | $197K |
| Jan 18, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700026C | 541711 | ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF | $697K |
| Sep 14, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700026C | 541711 | ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF | $24M |
| Oct 1, 2016 | Department of Veterans Affairs247-NETWORK CONTRACT OFFICE 7 (36C247) | 36C24718K0150 | 325412 | EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR PHARMACEUTICALS FOR FY17 | $12K |
| Mar 3, 2016 | Department of Veterans Affairs688-WASHINGTON DC | VA24516F0439 | 325412 | PHARMACEUTICALS FOR DIRECT PATIENT CARE. | $8K |
| Oct 23, 2015 | Department of Veterans Affairs258-NETWORK CONTRACT OFFICE 18 | VA25816J0125 | 325412 | EMERGENCY PURCHASE OF AFINITOR, CANCER DRUG FOR PHX VA FACILITY. | $27K |
Get Alerted Before Novartis Pharmaceuticals Corporation's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free